Humana Inc. $HUM Shares Acquired by High Ground Investment Management LLP

Key Points

• High Ground Investment Management LLP increased its stake in Humana Inc. by 15.1%, now holding 495,383 shares, making Humana approximately 25.4% of its total portfolio.
• Humana reported a quarterly EPS of $6.27, which missed estimates by $0.05, despite revenues of $32.39 billion exceeding expectations.
• The company recently declared a quarterly dividend of $0.885, indicating a 1.4% yield, with a payout ratio of 27.17%.

High Ground Investment Management LLP increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 15.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 495,383 shares of the insurance provider's stock after purchasing an additional 64,885 shares during the period. Humana makes up about 25.4% of High Ground Investment Management LLP's holdings, making the stock its 2nd biggest position. High Ground Investment Management LLP owned 0.41% of Humana worth $121,111,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC grew its stake in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after purchasing an additional 46 shares during the period. Riverview Trust Co bought a new position in Humana in the first quarter worth approximately $34,000. Garde Capital Inc. bought a new position in Humana in the first quarter worth approximately $36,000. Zions Bancorporation National Association UT bought a new position in Humana in the first quarter worth approximately $37,000. Finally, Whipplewood Advisors LLC boosted its holdings in Humana by 639.1% in the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock worth $45,000 after acquiring an additional 147 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on HUM shares. Royal Bank Of Canada increased their price target on Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a report on Thursday, August 21st. Robert W. Baird cut their price target on Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Piper Sandler cut their price target on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Barclays increased their price target on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a report on Friday, September 5th. Finally, Evercore ISI began coverage on Humana in a report on Monday. They issued an "in-line" rating and a $295.00 target price on the stock. Seven analysts have rated the stock with a Buy rating and seventeen have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $289.50.

Humana Stock Performance

Shares of Humana stock opened at $257.96 on Wednesday. The business's fifty day simple moving average is $269.90 and its 200 day simple moving average is $257.23. The firm has a market capitalization of $31.02 billion, a P/E ratio of 19.80, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $324.38. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business's revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana's payout ratio is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.